Table 1.
Basic information of patients.
| Patient | Sex | Age (years) | Height (cm) | Weight (kg) | Diagnosis | Dose (mCi) | Duration of PET/MRI after injection (min) | Clinical indication |
|---|---|---|---|---|---|---|---|---|
| 1 | F | 55 | 162.0 | 62.0 | Lung cancer | 7.39 | 61 | Follow-up |
| 2 | F | 71 | 152.0 | 70.0 | Cerebral metastasis | 8.33 | 98 | Diagnosis |
| 3 | M | 57 | 172.0 | 68.0 | Rectal cancer | 8.65 | 114 | Restaging |
| 4 | M | 65 | 180.0 | 87.5 | Lymphoma | 10.49 | 99 | Staging |
| 5 | M | 64 | 170.0 | 64.0 | Esophageal cancer, lung cancer | 8.22 | 104 | Staging |
| 6 | M | 66 | 167.0 | 76.0 | Pancreatic cancer | 9.52 | 146 | Staging |
| 7 | M | 17 | 174.0 | 72.0 | Thyroid cancer | 8.60 | 94 | Diagnosis |
| 8 | M | 69 | 162.0 | 67.0 | Enterocoelic sarcoma | 8.65 | 120 | Staging |
| 9 | F | 73 | 157.0 | 63.0 | Ovarian cancer | 7.05 | 96 | Staging |
| 10 | F | 50 | 165.0 | 54.0 | Pancreatic cancer | 6.99 | 87 | Staging |
| 11 | F | 65 | 163.0 | 58.0 | Cholangiocarcinoma | 6.87 | 101 | Staging |
| 12 | M | 66 | 164.0 | 51.0 | Esophageal cancer | 6.13 | 102 | Staging |
| 13 | F | 51 | 161.0 | 67.0 | Rectal cancer | 8.01 | 90 | TRE |
| 14 | F | 68 | 161.0 | 63.0 | Lung cancer | 7.33 | 87 | Staging |
| 15 | M | 46 | 170.0 | 105.0 | Liver cancer | 13.61 | 162 | Diagnosis |
| 16 | M | 62 | 175.0 | 75.0 | Lung cancer | 9.33 | 88 | Staging |
| 17 | M | 70 | 170.0 | 70.0 | Duodenal cancer | 8.82 | 96 | Staging |
| 18 | M | 70 | 162.0 | 69.0 | Lung cancer | 8.20 | 119 | Staging |
| 19 | M | 64 | 164.0 | 61.0 | Colon cancer | 8.50 | 117 | Staging |
| 20 | M | 63 | 168.0 | 68.0 | Gastric cancer | 8.57 | 94 | TRE |
| 21 | M | 65 | 172.0 | 71.0 | Colon cancer | 8.85 | 107 | Staging |
| 22 | M | 69 | 170.0 | 72.0 | Pancreatic cancer | 9.99 | 115 | Diagnosis |
| 23 | M | 54 | 151.0 | 52.0 | Liver cancer | 6.40 | 66 | Staging |
| 24 | M | 46 | 173.0 | 84.0 | Liposarcoma in teres major | 10.71 | 103 | Staging |
| 25 | M | 60 | 171.0 | 73.8 | Liver cancer | 3.64 | 94 | TRE |
| 26 | M | 75 | 173.0 | 74.0 | Liver cancer | 9.38 | 107 | Restaging |
| 27 | F | 60 | 156.0 | 56.0 | Duodenal cancer | 6.69 | 114 | Staging |
| 28 | M | 51 | 174.0 | 85.0 | Liver cancer | 10.08 | 93 | Diagnosis |
| 29 | M | 61 | 172.0 | 70.5 | Lymphoma | 8.45 | 82 | Diagnosis |
| 30 | F | 69 | 156.0 | 60.0 | Liver cancer | 8.63 | 95 | Diagnosis |
| Mean | 60.7 | 166.2 | 69.0 | 8.40 | 101.7 | |||
| SD | 11.2 | 7.1 | 11.1 | 1.72 | 19.6 |
Note: M, male; F, female; SD, standard deviation; TRE, therapy-response evaluation.